Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™ for Treatment of OA of the First CMC
Clinical trial NCT00423371 · COMPLETED
Trial details
- NCT number
- NCT00423371
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2007-09-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.